TNFSF11 and Hashimoto thyroiditis: Hashimoto disease can have a unique impact on the the osteoprotegerin/receptor activator of nuclear factor kappa-B ligand (OPG/RANKL) system, apart from the hypothyroidism, potentially leading to additional bone loss [21].